Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway.

Santos SC, Lacronique V, Bouchaert I, Monni R, Bernard O, Gisselbrecht S, Gouilleux F.

Oncogene. 2001 Apr 19;20(17):2080-90.


Characterization of a novel ETS gene, TELB, encoding a protein structurally and functionally related to TEL.

Poirel H, Lopez RG, Lacronique V, Della Valle V, Mauchauffé M, Berger R, Ghysdael J, Bernard OA.

Oncogene. 2000 Sep 28;19(41):4802-6.


TEL-JAK2 transgenic mice develop T-cell leukemia.

Carron C, Cormier F, Janin A, Lacronique V, Giovannini M, Daniel MT, Bernard O, Ghysdael J.

Blood. 2000 Jun 15;95(12):3891-9.


Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.

Lacronique V, Boureux A, Monni R, Dumon S, Mauchauffé M, Mayeux P, Gouilleux F, Berger R, Gisselbrecht S, Ghysdael J, Bernard OA.

Blood. 2000 Mar 15;95(6):2076-83.


Analysis of TEL proteins in human leukemias.

Poirel H, Lacronique V, Mauchauffé M, Le Coniat M, Raffoux E, Daniel MT, Erickson P, Drabkin H, MacLeod RA, Drexler HG, Ghysdael J, Berger R, Bernard OA.

Oncogene. 1998 Jun 4;16(22):2895-903.


Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux.

Shimizu S, Eguchi Y, Kamiike W, Funahashi Y, Mignon A, Lacronique V, Matsuda H, Tsujimoto Y.

Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1455-9.


Regulation of the specific DNA binding activity of Xenopus laevis p53: evidence for conserved regulation through the carboxy-terminus of the protein.

Bessard AC, Garay E, Lacronique V, Legros Y, Demarquay C, Houque A, Portefaix JM, Granier C, Soussi T.

Oncogene. 1998 Feb 19;16(7):883-90.


A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia.

Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffé M, Berthou C, Lessard M, Berger R, Ghysdael J, Bernard OA.

Science. 1997 Nov 14;278(5341):1309-12.


Bcl-2 targeted overexpression into the erythroid lineage of transgenic mice delays but does not prevent the apoptosis of erythropoietin-deprived erythroid progenitors.

Lacronique V, Varlet P, Mayeux P, Porteu A, Gisselbrecht S, Kahn A, Lacombe C.

Blood. 1997 Oct 15;90(8):3050-6.


Chromosome abnormalities of the short arm of chromosome 12 in hematopoietic malignancies: a report including three novel translocations involving the TEL/ETV6 gene.

Berger R, Le Coniat M, Lacronique V, Daniel MT, Lessard M, Berthou C, Marynen P, Bernard O.

Leukemia. 1997 Sep;11(9):1400-3.


Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice.

Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, Porteu A, Henrion A, Bouscary D, Varlet P, Joulin V, Kahn A.

Nat Med. 1996 Jan;2(1):80-6.


Identification and functional characterization of an erythroid-specific enhancer in the L-type pyruvate kinase gene.

Lacronique V, Lopez S, Miquerol L, Porteu A, Kahn A, Raymondjean M.

J Biol Chem. 1995 Jun 23;270(25):14989-97.


Three novel sequence variations in the 5' upstream region of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: two polymorphisms and one putative molecular defect.

Bienvenu T, Lacronique V, Raymondjean M, Cazeneuve C, Hubert D, Kaplan JC, Beldjord C.

Hum Genet. 1995 Jun;95(6):698-702.


In vitro and in vivo protein--DNA interactions on the rat erythroid-specific L' pyruvate kinase gene promoter.

Lacronique V, Boquet D, Lopez S, Kahn A, Raymondjean M.

Nucleic Acids Res. 1992 Nov 11;20(21):5669-76.

Supplemental Content

Loading ...
Support Center